Taiyen Biotech Co Ltd Capital Reinvestment Ratio
Taiyen Biotech Co Ltd capital reinvestment ratio. Taiyen Biotech Co Ltd (1737) has a Capital Reinvestment Ratio of 0.38x as of June 2026, meaning it reinvests 0% of its operating cash flow (NT$99.80 Million) in capital expenditures (NT$38.03 Million). Check Taiyen Biotech Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Taiyen Biotech Co Ltd (2003–2025)
Capital reinvestment ratio of Taiyen Biotech Co Ltd from 2003 to 2025. This chart tracks Taiyen Biotech Co Ltd's Capital Reinvestment Ratio across 23 annual periods. Also explore Taiyen Biotech Co Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Taiyen Biotech Co Ltd Capital Reinvestment Ratio by Year (2003–2025)
Taiyen Biotech Co Ltd capital reinvestment ratio by year from 2003 to 2025. For the full cash flow conversion analysis, see Taiyen Biotech Co Ltd (1737) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.63x | NT$473.77 Million | NT$300.16 Million | ▲ +36.0% |
| 2024 | 0.47x | NT$660.12 Million | NT$307.61 Million | ▼ -38.6% |
| 2023 | 0.76x | NT$454.54 Million | NT$345.13 Million | ▲ +78.8% |
| 2022 | 0.42x | NT$580.69 Million | NT$246.60 Million | ▼ -34.8% |
| 2021 | 0.65x | NT$600.08 Million | NT$390.81 Million | ▼ -17.5% |
| 2020 | 0.79x | NT$339.36 Million | NT$267.89 Million | ▼ -8.1% |
| 2019 | 0.86x | NT$330.81 Million | NT$284.25 Million | ▲ +29.5% |
| 2018 | 0.66x | NT$449.83 Million | NT$298.49 Million | ▲ +9.1% |
| 2017 | 0.61x | NT$607.87 Million | NT$369.68 Million | ▲ +81.5% |
| 2016 | 0.33x | NT$568.06 Million | NT$190.30 Million | ▲ +20.7% |
| 2015 | 0.28x | NT$383.93 Million | NT$106.57 Million | ▼ -30.8% |
| 2014 | 0.40x | NT$371.06 Million | NT$148.81 Million | ▼ -12.9% |
| 2013 | 0.46x | NT$203.21 Million | NT$93.53 Million | ▼ -35.0% |
| 2012 | 0.71x | NT$154.46 Million | NT$109.40 Million | ▲ +126.8% |
| 2011 | 0.31x | NT$246.09 Million | NT$76.85 Million | ▼ -25.5% |
| 2010 | 0.42x | NT$300.89 Million | NT$126.08 Million | ▲ +30.8% |
| 2009 | 0.32x | NT$358.02 Million | NT$114.67 Million | ▼ -30.4% |
| 2008 | 0.46x | NT$417.51 Million | NT$192.08 Million | ▲ +86.2% |
| 2007 | 0.25x | NT$322.49 Million | NT$79.70 Million | ▼ -22.9% |
| 2006 | 0.32x | NT$462.88 Million | NT$148.45 Million | ▲ +43.0% |
| 2005 | 0.22x | NT$575.91 Million | NT$129.19 Million | ▲ +229.6% |
| 2004 | 0.07x | NT$2.84 Billion | NT$192.93 Million | ▲ +146.5% |
| 2003 | 0.03x | NT$3.42 Billion | NT$94.39 Million | — |